Product logins

Find logins to all Clarivate products below.


How should pharma leverage online resources and HCPs differently throughout the patient journey? | Cybercitizen Health Europe 2016 | Strategic Insight

Even with DTC regulations in the EU, info-seeking consumers are just as likely to use online sources to access prescription drug information as they are to use their healthcare providers for such information. While HCPs are still the predominant and most influential source for prescription drug information, internet is a powerful tool as well, and EU pharma companies would be wise to not discount it.  How should pharma leverage online resources and HCPs differently throughout the patient journey? This Strategic Insight covers the essentials.

Related Multichannel Engagement Reports

Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | Pneumococcal Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the…
Report
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines
Patient Omnichannel Insights | Cybercitizen Health | 2023 | US | HPV Vaccines Our 2023 study among patients and caregivers provides detailed insights and recommendations on the information-…
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | Colombia (Segmentation Data Tables)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma | Segmentation
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | Multiple Myeloma (Segmentation Data Deck)
Report
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM | Segmentation Data
Patient Multichannel Insights | 2022 | Cybercitizen Health | US | AML VS CLL VS MM (Segmentation Data Comparison Table)